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Objectives: Metabolic dysfunction is a common hallmark of the aging process and
aging-related pathogenesis. Blood metabolites have been used as biomarkers for
many diseases, including cancers, complex chronic diseases, and neurodegen-
erative diseases.
Methods: In order to identify aging-related biomarkers from blood metabolites,
we investigated the specific metabolite profiles of mouse sera from 4-month-old
and 21-month-old mice by using a combined flow injection analysisetandem mass
spectrometry and liquid chromatographyetandem mass spectrometry.
Results: Among the 156 metabolites detected, serum levels of nine individual
metabolites were found to vary with aging. Specifically, lysophosphatidylcholine
(LPC) acyl (a) C24:0 levels in aged mice were decreased compared to that in
young mice, whereas phosphatidylcholine (PC) acyl-alkyl (ae) C38:4, PC ae
C40:4, and PC ae C42:1 levels were increased. Three classes of metabolites
(amino acids, LPCs, and PCs) differed in intraclass correlation patterns of the
individual metabolites between sera from young and aged mice. Additionally, the
ratio of LPC a C24:0 to PC ae C38:4 was decreased in the aged mice, whereas the
ratio of PC ae C40:4 to LPC a C24:0 was increased, supporting the aging-related
metabolic changes of glycerophospholipids.
Conclusion: The ratios of the individual metabolites PC and LPC could serve as
potential biomarkers for aging and aging-related diseases.1. Introduction
Aging is an irreversible and progressive, multidi-
mensional, complex process that includes the accumu-
lation of cellular and organ damage, leading to a decline
in function [1,2]. Aging is also known to be a risk factorted under the terms of the C
0) which permits unrestrict
roperly cited.
ase Control and Preventionfor many prevalent diseases such as diabetes, cancers,
and cardiovascular and neurodegenerative diseases (e.g.
Alzheimer’s and Parkinson’s diseases) [3]. Therefore,
the discovery of aging and aging-related disease bio-
markers is important for the early diagnosis and therapy
of diseases.reative Commons Attribution Non-Commercial License (http://
ed non-commercial use, distribution, and reproduction in any
. Published by Elsevier Korea LLC. All rights reserved.
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ted to understand the underlying biological process to
develop disease biomarkers [4]. In particular, metab-
olomic analysis is suitable for the discovery of aging-
related biomarkers because it has been shown that
metabolic dysfunction is a common hallmark of the
aging process [5]. The utility of targeted metabolomics
for the discovery and validation of disease biomarkers
has been recently established [6]. Although metab-
olomic studies have resulted in the identification of
aging-related biomarkers from human samples [7e9]
and animal models [5,10,11], consistent blood bio-
markers of the aging process still need to be identified.
Phospholipids can function as pathogenic indicators
of many diseases such as Alzheimer’s disease [12e15],
ovarian endometriosis [16], and rheumatoid arthritis
[17]. Phosphatidylcholine (PC) is a major component of
phospholipids. It was reported that rat plasma phos-
pholipids consist of PCs (w70% of total phospholipids),
very low-density lipoproteins with sphingomyelin (SM;
11%), lysophosphatidylcholine (LPC; 3%), phosphati-
dylethanolamine (4%), and phosphatidylinositol (3%)
[18]. LPCs are generated by the hydrolysis of PCs by
phospholipase A2, which plays an important role in in-
flammatory responses [19].
The purpose of this study was to examine aging-
related changes in serum concentrations of metabolites
in young and aged mice to further increase our under-
standing of the metabolite-related aging process. We
found the ratios of LPC acyl (a) C24:0 to PC acyl-alkyl
(ae) C38:4 and PC ae C40:4 to LPC a C24:0 were
significantly different among sera from young and aged
mice. These results suggest that the ratios of PC and
LPC levels could provide aging-related metabolic in-
formation from blood as well as provide clues for the
identification of antiaging molecular targets.2. Materials and methods
2.1. Animals
C57BL6/J mice were purchased from The Laboratory
Animal Resource Center, Korea Research Institute of
Bioscience & Biotechnology (KRIBB; Ochang,
Chungcheongbuk-do, Korea). All mice were maintained
in a specific-pathogen free area, according to standard
animal care protocols. Whole blood was collected via
heart puncture following euthanasia by cervical dislo-
cation. Collected blood was incubated for 20 minutes at
room temperature in Serum Separator Tubes (BD
Bioscience, Franklin Lakes, NJ, USA), and clots were
then removed by centrifugation at 1500  g. Sera were
stored at 70C until needed.
2.2. Metabolite quantification
Targeted metabolite concentrations were measured
using the Absolute IDQ p180 Kit (Biocrates LifeSciences AG, Innsbruck, Austria). The assay procedures
have been previously described in detail [20]. Serum
metabolites were quantified using appropriate internal
standards included in the kit. The 186 metabolites tar-
geted included 40 acylcarnitines (ACs), 21 amino acids
(AAs), 19 biogenic amines (BAs), 14 LPCs, 38 PC
diacyl, 38 PC ae, 15 SMs, and the sum of hexoses (H1).
In brief, AAs and BAs were measured by liquid chro-
matographyetandem mass spectrometry, and ACs,
phospho- and sphingolipids, and hexoses were measured
by flow injection analysisetandem mass spectrometry
on API 4000 QTRAP (ABSCIEX, Framingham, MA,
USA). To ensure data quality, metabolites coefficient of
variance (CV) that was under 20% and above the limit
of detection (LOD) were selected. The CV and LOD
criteria were passed by 156 metabolites. Concentrations
of all detected metabolites are reported as mM.
2.3. Statistical analysis
Statistical analysis was performed using three
different methods, including t test and additional
BiomarkeR and limma packages in Bioconductor (http://
www.bioconductor.org), to identify statistically powerful
biomarkers. The BiomarkeR package in Bioconductor
has a network-based approach to identify biomarkers in
metabolomics research [21]. It provides the biomarker
identifier (BI) score by measuring the change of each
metabolite and connectivity of the metabolites within the
network. The measured metabolite data were imported
into the BiomarkeR package and analyzed with the un-
paired BI method. The selected biomarkers were plotted
with the unpaired BI Graph method. Next, for the linear
modeling approach, the concentration of each metabolite
was transformed by log and normalized with the quantile
normalization method. Then, we employed the limma
package in Bioconductor that is designed to stabilize the
analysis with linear modeling. The p-values were
adjusted for multiple tests. Volcano plots were con-
structed using an empirical Bayes method in the limma
package. The metabolite serum concentrations were
normally distributed as indicated by the Kolmogor-
oveSmirnov test. All statistical analyses were carried
out using SPSS version 20 (SPSS Inc., Chicago, IL,
USA) and R program (http://www.R-project.org).3. Results
We used a targeted metabolomic analysis to identify
aging-related biomarkers and specific profiles of serum
metabolites in the aging process. We investigated seven
classes of metabolites (ACs, BAs, AAs, LPCs, PCs,
SMs, and hexoses) from young and aged mice. Of these
186 metabolites, 156 were detected in mouse sera at
levels above the LOD. Via statistical analysis, we found
changes in serum concentrations of 23 metabolites in the
young (4-month-old) and aged (21-month-old) mice
Table 2. Top 10 ranked metabolites selected by




LPC a C17:0 167.8
C0 159.3
PC ae C42:1 143.2
Spermidine 135.5




a Z acyl; ae Z acyl-alkyl; LPC Z lysophosphatidylcholines;
PC Z phosphatidylcholines.
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ACs (nZ 6), BAs (nZ 4), LPCs (nZ 2), PCs (nZ 8),
and SMs (n Z 3). Of these five classes of metabolites,
ACs, LPCs, and SMs were all decreased in sera from
aged mice, compared with sera from young mice. By
contrast, members of the BA and PC classes were either
increased or decreased in aged mice, compared with
young mice, thus not displaying intraclass consistency.
For aging biomarker identification, we employed a
recently published statistical biomarker discovery strat-
egy, the BiomarkeR algorithm [21,22]. The BiomarkeR
software was utilized for biomarker identification using
a BI score and connectivity strength within the
biochemical network of metabolites. The top 10 ranked
metabolites and their BI scores are listed in Table 2.
According to BiomarkeR algorithm analysis, glutamate,
kynurenine, LPC a C17:0, and carnitine (C0) exhibited
the top four BI scores, but these metabolites were not
represented as significant in the t test (glutamate, LPC a
C17:0, and C0) or volcano plot (kynurenine, LPC a
C17:0, and C0; Table 3). In addition to the BI score
method, we also used a volcano plot to analyzeTable 1. Changes in serum metabolite concentrations between
Metabolite Younga
AC
C14 0.09  0.01 0.
C16 0.24  0.01 0.
C18 0.06  0.01 0.
C18:1 0.21  0.00 0.
C2 26.88  1.29 19.
C5-OH 0.10  0.01 0.
BA
Kynurenine 0.89  0.11 1.
Sarcosine 5.49  0.62 3.
Spermidine 6.79  0.85 3.
Spermine 1.05  0.08 0.
LPC
LPC a C16:0 424.54  1.86 399.
LPC a C24:0 0.73  0.07 0.
PC
PC aa C28:1 0.17  0.01 0.
PC aa C34:3 18.06  0.30 20.
PC aa C42:6 1.96  0.03 1.
PC ae C34:1 6.01  0.21 5.
PC ae C38:4 4.70  0.47 5.
PC ae C38:6 3.75  0.12 3.
PC ae C40:4 2.11  0.12 2.
PC ae C42:1 0.53  0.10 0.
SM
SM C16:1 6.15  0.12 4.
SM C18:0 3.21  0.14 2.
SM C24:0 14.34  0.33 10.
aMetabolite concentrations are expressed as the mean standard deviation in mM
in aged mouse serum samples compared to the young mouse serum samples. *
BA Z biogenic amines; C14 Z tetradecanoylcarnitine; C16 Z hexadecanoyl
C2 Z acetylcarnitine; C5-OH Z hydroxyvalerylcarnitine; LPC Z lysophosphametabolite profiles by log transformation of the p-value
and fold-change (Figure 1). Thirteen metabolites dis-
played significantly different serum concentrations be-
tween young and aged mouse sera (Table 3). Finally, our
three different statistical analyses allowed for theyoung and aged mice.
Ageda Up or downb p*
07  0.01 Y 0.035
16  0.02 Y 0.006
05  0.01 Y 0.048
19  0.00 Y 0.001
53  1.75 Y 0.004
07  0.01 Y 0.003
09  0.05 [ 0.040
29  1.20 Y 0.048
61  0.57 Y 0.006
72  0.06 Y 0.004
76  13.25 Y 0.033
56  0.06 Y 0.039
22  0.02 [ 0.017
08  1.19 [ 0.046
40  0.15 Y 0.004
18  0.44 Y 0.042
78  0.38 [ 0.037
03  0.31 Y 0.020
76  0.29 [ 0.024
75  0.08 [ 0.040
79  0.78 Y 0.041
72  0.18 Y 0.021
06  1.44 Y 0.007
; bUp or down indicates increase or decrease in metabolite concentrations
t-test comparison between young and aged mice. AC Z acylcarnitines;
carnitine; C18 Z octadecanoylcarnitine; C18:1 Z octadecanoylcarnitine;
tidylcholines; PC Z phosphatidylcholines; SM Z sphingomyelins.
Table 3. Statistical selection of age-related metabolites.
Metabolite p* BI scorea Adjusted p**
AC
C0 NS 159.3 NS
C14 0.035 125.1 0.025
C5-OH 0.003 123.4 0.036
AA
Glutamate NS 275.9 0.019
BA
kyneurenine 0.040 195.3 NS
Sarcosine 0.048 128.4 0.044
Spermidine 0.006 135.5 0.041
LPC
LPC a C17:0 NS 167.8 NS
LPC a C24:0 0.039 112.4 0.002
PC
PC ae C38:4 0.037 133.4 0.001
PC ae C40:4 0.024 117.9 0.022
PC ae C42:1 0.040 143.2 0.005
SM
SM C24:0 0.007 120.8 0.013
aBiomarker identifier (BI) score results from BiomarkeR algorithm.
*t test comparison between the groups. ** Results from limma package.
The p value is adjusted by Benjamini and Hochberg method. a Z acyl;
AC Z acylcarnitines; ae Z acyl-alkyl; AA Z amino acids;
BA Z biogenic amines; LPC Z lysophosphatidylcholines; NS Z not
significant (p > 0.05); PC Z phosphatidylcholines;
SM Z sphingomyelins.
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involving nine metabolites, namely, tetradeca-
noylcarnitine (C14), hydroxyvalerylcarnitine (C5-OH),
sarcosine, spermidine, LPC a C24:0, PC ae C38:4,
C40:4, C42:1, and SM C24:0.Figure 1. Volcano plot of metabolite profiles. The volcano
plot was depicted as a log scaled axes of fold change (x-axis)
and p-value (y-axis) for visualization. Metabolites with a sig-
nificant difference (adjusted p < 0.05) are named in the plot.
aZ acyl; ae Z acyl-alkyl; LPCZ lysophosphatidylcholines;
PC Z phosphatidylcholines; SM Z sphingomyelins.We calculated pair-wise correlation coefficients of
individual metabolites of either young or aged mice
(Figure 2). Higher intraclass correlation coefficients
were observed for AAs in young mouse sera, but not in
aged mouse sera. On the contrary, metabolite classes of
PCs and LPCs displayed higher pair-wise correlation
coefficients in aged mice relative to the young mice.
This suggests that the relative ratios of individual me-
tabolites within a particular intraclass may play an
important role in the aging process.
Next, we examined the pair-wise ratios of nine in-
dividual metabolites that were selected using the three
statistical methods and compared the difference of the
ratios between young and aged mice. It is likely that the
relative ratios of metabolite pairs within the sample may
reduce experimental bias due to sample variation, aiding
in the generation of more reliable results. The Bonfer-
roni correction was used for multiple comparisons. The
ratios of LPC a C24:0 to PC ae C38:4 and PC ae C40:4
to LPC a C24:0 were significantly different (9  8Z 72
pair-wise ratios, p < 0.00069) between young and aged
mice (Table 4). The ratio of LPC a C24:0 to PC ae
C38:4 was decreased in aged mice whereas the ratio of
PC ae C40:4 to LPC a C24:0 was increased, relative to
the ratios observed in young mice.Figure 2. Comparison of pair-wise correlation coefficients of
all of detected serum metabolites. Solid boxes indicate correla-
tion coefficients (>0.9) of pairs of twometabolites. AAZ amino
acids; AC Z acylcarnitines; BA Z biogenic amines;
LPCZ lysophosphatidylcholines; PCZ phosphatidylcholines;
SMZ sphingomyelins.
Table 4. Significant metabolite pairs between young and aged mice.
Ratio of pair metabolites
Concentration ratio
p*Young Aged
LPC a C24:0/PC ae C38:4 0.155  0.002 0.097  0.007 1.460E-04
PC ae C40:4/LPC a C24:0 2.916  0.225 4.918  0.006 1.044E-04
Data are expressed as concentration (mM) of relative ratios of paired metabolites, mean  standard deviation for three mice per group. * Results from
Bonferroni correction. a Z acyl; ae Z acyl-alkyl; LPC Z lysophosphatidylcholines; PC Z phosphatidylcholines.
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We measured metabolite concentrations from young
and aged mouse sera by using targeted metabolomics
coupled with multiple statistical methods to identify
aging-related biomarkers. The ratios of both LPC a
C24:0 to PC ae C38:4 and PC ae C40:4 to LPC a C24:0
exhibited significant difference (p < 0.00069, after the
Bonferroni correction) between young and aged mice.
These results suggest that the relative concentrations of
PCs to LPCs may provide a clue for the development of
aging-related biomarkers in blood samples.
In this study, we successfully quantified the serum
concentrations of 156 out of 186 metabolites; detection
of the other 30 metabolites probably failed because the
kit used in this study was originally designed for the
range of metabolite concentrations from human sam-
ples. Among the metabolites quantified, 23 displayed a
significant difference (p < 0.05) in serum concentrations
between young and aged mice (Table 1).
Decreased levels of ACs (excluding butyrylcarnitine
and valeryl-L-carnitine) and BAs (excluding histamine
and kynurenine) were observed in the sera from aged
mice. It was recently reported that plasma AC levels are
associated with diabetes [23], myocardial infarction
[24], and impaired muscle function in elderly men [25].
However, the relevance of alterations in blood AC levels
with aging are unknown. Polyamine (putrescine, sper-
midine, and spermine) levels were known to decrease
with aging in many organisms [26]. In this study,
spermidine and spermine levels were significantly
decreased in the sera from aged mice, relative to young
mice. Therefore, ACs and polyamines were worthy of
further investigation regarding their involvement in
aging.
After our comprehensive statistical analysis, nine
metabolites [tetradecanoylcarnitine (C14), hydrox-
yvalerylcarnitine (C5-OH), sarcosine, spermidine, LPC
a C24:0, PC ae C38:4, PC ae C40:4, PC ae C42:1, and
SM C24:0] were identified as aging-related serum
metabolites. With the exception of PC ae C38:4 and PC
ae C40:4, the concentrations of selected metabolites
were decreased in aged mice, relative to young mice.
Some metabolomics studies have reported that ratios of
metabolite pairs can be used to reduce experimental
bias and provide statistical power for biomarkerdiscovery from disease samples [12,16,27]. In human
serum [27] and pig plasma [28] samples, the ratios of
AAs were found to be useful as biomarkers for knee
osteoarthritis and asphyxia. The ratios of PC and LPC
have also been promising targets in biomarker discov-
ery for many diseases. For example, the PC/LPC ratio
in human plasma was useful for indicating the severity
of rheumatoid arthritis [17] and the LPC/PC ratio in
human cerebrospinal fluid is decreased in Alzheimer’s
disease [12].
In this study, although significant changes in AA and
sugar levels were not observed between young and aged
mice, AAs exhibited high correlation coefficients with
intraclass metabolites in young mouse sera (Figure 2).
By contrast, aged mice displayed higher correlations of
metabolite concentrations within PCs or LPCs than
young mice. These results revealed that global patterns
of correlation coefficients of intraclass metabolites of
AAs, PCs, and LPCs might be useful as age-dependent
fingerprints of potential metabolite biomarkers for the
aging process.
Glycerol-based phospholipids, glycerophospholipids
(GPs), are important not only to maintain neural mem-
brane structure but also to provide suitable environment,
fluidity, and ion-permeability [29]. Changes in the
phospholipid content of neural cell membranes may
contribute to neurodegenerative diseases. Many studies
have been conducted to reveal a relationship between
lipid metabolism and neurodegenerative diseases such
as Alzheimer’s disease. Recently, plasma PC and
phospholipid levels were identified as potential diag-
nostic biomarkers for Alzheimer’s disease [14] and
predictive biomarkers for the conversion of preclinical
Alzheimer’s disease [15]. PC is the major phospholipid
of cellular membranes [30]. In fact, SM and LPC are
synthesized from PC via SM synthases and phospholi-
pase A2, respectively. This study reveals that the cor-
relation coefficients of PC, LPC, and SM are altered
with aging in mice. Further studies are needed to un-
cover the biological significance of the changes in GP
content in neurodegenerative disease pathogenesis and
potentially revealing a link to aging-dependent metab-
olite changes.
Many studies have demonstrated that blood meta-
bolic profiles are altered by aging in humans and mice.
A recent report indicated that some ACs, SMs, and PCs
350 S. Kim, et alincreased with age, while histidine was decreased [7].
Recent metabolomics studies have shown that the
analysis of metabolic profiles of mouse sera could pre-
dict biological age [10]. Houtkooper et al [5] reported
that levels of long chain ACs and various AAs were
decreased in the plasma of aged mice while free fatty
acid levels were increased. Consistent with that report,
our results also revealed that long-chain ACs (C14, C16,
C18 and C18:1) were significantly decreased (Table 1)
and some amino acids tended to be decreased in aged
mice.
Our results suggest that PC/LPC ratios can be
developed as metabolic indicators of the aging process,
providing better targets for antiaging and aging-related
disease therapy. To our knowledge, this is the first report
to identify the PC/LPC ratio as a potential biomarker of
aging. Therefore, further studies should extend to human
samples to investigate the biological relevance of PC
and LPC serum concentrations and other metabolite
ratios in the aging process.Conflicts of interest
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